Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals.
about
Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs.HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study.Precision medicine for HIV: where are we?Free and total plasma concentrations of elvitegravir/cobicistat during pregnancy and postpartum: a case report.
P2860
Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Population pharmacokinetic ana ...... in HIV-1-infected individuals.
@en
type
label
Population pharmacokinetic ana ...... in HIV-1-infected individuals.
@en
prefLabel
Population pharmacokinetic ana ...... in HIV-1-infected individuals.
@en
P2093
P2860
P50
P356
P1476
Population pharmacokinetic ana ...... in HIV-1-infected individuals.
@en
P2093
Catalina Barceló
Frédéric Gaspar
Manel Aouri
Margalida Rotger
Thierry Buclin
P2860
P304
P356
10.1093/JAC/DKW050
P407
P50
P577
2016-03-29T00:00:00Z